CZ2799A3 - Deriváty benzo[g]chinolinu - Google Patents

Deriváty benzo[g]chinolinu Download PDF

Info

Publication number
CZ2799A3
CZ2799A3 CZ9927A CZ2799A CZ2799A3 CZ 2799 A3 CZ2799 A3 CZ 2799A3 CZ 9927 A CZ9927 A CZ 9927A CZ 2799 A CZ2799 A CZ 2799A CZ 2799 A3 CZ2799 A3 CZ 2799A3
Authority
CZ
Czechia
Prior art keywords
free base
compound
formula
methyl
quinoline
Prior art date
Application number
CZ9927A
Other languages
Czech (cs)
English (en)
Inventor
Peter Gull
Rudolf Markstein
Max Peter Seiler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614282.3A external-priority patent/GB9614282D0/en
Priority claimed from GBGB9626093.0A external-priority patent/GB9626093D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CZ2799A3 publication Critical patent/CZ2799A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ9927A 1996-07-08 1997-07-07 Deriváty benzo[g]chinolinu CZ2799A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9614282.3A GB9614282D0 (en) 1996-07-08 1996-07-08 Organic compounds
GBGB9626093.0A GB9626093D0 (en) 1996-12-16 1996-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
CZ2799A3 true CZ2799A3 (cs) 1999-03-17

Family

ID=26309658

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ9927A CZ2799A3 (cs) 1996-07-08 1997-07-07 Deriváty benzo[g]chinolinu

Country Status (28)

Country Link
US (1) US6057334A (zh)
EP (1) EP0912553B1 (zh)
JP (1) JP4216337B2 (zh)
KR (1) KR100491478B1 (zh)
CN (1) CN1125065C (zh)
AR (1) AR007814A1 (zh)
AT (1) ATE211470T1 (zh)
AU (1) AU719119B2 (zh)
BR (1) BR9710218A (zh)
CA (1) CA2257646C (zh)
CO (1) CO4870760A1 (zh)
CY (1) CY2322B1 (zh)
CZ (1) CZ2799A3 (zh)
DE (1) DE69709869T2 (zh)
DK (1) DK0912553T3 (zh)
ES (1) ES2170402T3 (zh)
HK (1) HK1020569A1 (zh)
ID (1) ID18896A (zh)
IL (1) IL127376A (zh)
NO (1) NO319401B1 (zh)
NZ (1) NZ333311A (zh)
PE (1) PE87998A1 (zh)
PL (1) PL330723A1 (zh)
PT (1) PT912553E (zh)
SK (1) SK399A3 (zh)
TR (1) TR199900016T2 (zh)
TW (1) TW378209B (zh)
WO (1) WO1998001444A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA
EG24415A (en) * 2002-03-07 2009-05-25 Novartis Ag Quinoline derivatives
PT1757601E (pt) * 2002-03-07 2009-10-23 Novartis Ag Derivados de quinolina e sua utilização em glaucoma e miopia
EP1663230A1 (en) * 2003-09-05 2006-06-07 Novartis AG Compositions comprising benzo(g)quinoline derivatives and prostaglandin derivatives
CN105434439B (zh) * 2015-11-11 2018-07-24 温州医科大学 一种多巴胺d2受体的部分激动剂在制备抑制近视药物上的应用及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3280252D1 (de) * 1981-10-16 1990-10-31 Sandoz Ag 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.
AU3879789A (en) * 1988-07-22 1990-02-19 Sandoz Ag Use of benzo(g)quinolines in treatment of nicotine addiction
GB8829330D0 (en) * 1988-12-16 1989-02-01 Sandoz Ltd Improvements in or relating to organic compounds
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
FR2729145A1 (fr) * 1995-01-06 1996-07-12 Smithkline Beecham Lab Nouveaux derives d'amine, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques

Also Published As

Publication number Publication date
PE87998A1 (es) 1998-12-30
ID18896A (id) 1998-05-20
SK399A3 (en) 1999-06-11
AU3542297A (en) 1998-02-02
IL127376A (en) 2003-12-10
NO990035L (no) 1999-01-05
CY2322B1 (en) 2003-11-14
KR20000023572A (ko) 2000-04-25
JP2000514075A (ja) 2000-10-24
KR100491478B1 (ko) 2005-05-27
EP0912553B1 (en) 2002-01-02
NZ333311A (en) 2000-06-23
ES2170402T3 (es) 2002-08-01
TR199900016T2 (xx) 1999-04-21
PL330723A1 (en) 1999-05-24
DK0912553T3 (da) 2002-04-22
PT912553E (pt) 2002-06-28
IL127376A0 (en) 1999-10-28
NO319401B1 (no) 2005-08-08
US6057334A (en) 2000-05-02
DE69709869T2 (de) 2002-08-14
TW378209B (en) 2000-01-01
CA2257646A1 (en) 1998-01-15
CN1225093A (zh) 1999-08-04
NO990035D0 (no) 1999-01-05
DE69709869D1 (de) 2002-02-28
WO1998001444A1 (en) 1998-01-15
JP4216337B2 (ja) 2009-01-28
ATE211470T1 (de) 2002-01-15
AU719119B2 (en) 2000-05-04
CO4870760A1 (es) 1999-12-27
BR9710218A (pt) 1999-08-10
AR007814A1 (es) 1999-11-24
EP0912553A1 (en) 1999-05-06
CN1125065C (zh) 2003-10-22
CA2257646C (en) 2006-05-09
HK1020569A1 (en) 2000-05-12

Similar Documents

Publication Publication Date Title
EP0079545B1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
IE913202A1 (en) 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha¹adrenergic agents
JPH0717633B2 (ja) ヘテロアリールピペラジン抗精神病薬
JPH07291964A (ja) 新規ベンズイミダゾ−ルのピペリジン誘導体
CZ316497A3 (cs) Nové heterocyklické sloučeniny
JP2002533395A (ja) 痛みを処置するための(2−イミダゾリン−2−イルアミノ)キノキサリン誘導体
JP2010024243A (ja) 緑内障および近視を処置するためのベンゾ[g]キノリン誘導体
KR20090023621A (ko) 9-하이드록시 엘립티신 유도체를 이용한 악성 표현형의 복구
JP2010095550A (ja) キノリン誘導体
US20050176763A1 (en) 3-Thia-4-arylquinolin-2-one potassium channel modulators
CZ2799A3 (cs) Deriváty benzo[g]chinolinu
PT912556E (pt) Derivados de indolina uteis como antagonistas do receptor de 5-ht-2c
DE10315285A1 (de) Chromenonindole
AU2002328856A1 (en) Benzo (G) quinoline derivatives for treating glaucoma and myopia
AU2014285301A1 (en) Phenylimidazole derivative, and therapeutic medicine or preventive medicine for inflammatory disease, etc.

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic